Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_assertion type Assertion NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_head.
- NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_assertion description "[Overactivation or dysfunction of the endothelin (ET) system modulates the progression of hypertension or kidney diseases with the ET(A) receptor primarily mediating vasoconstriction, injury and anti-natriuresis, and ET(B) receptors having opposite effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_provenance.
- NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_assertion evidence source_evidence_literature NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_provenance.
- NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_assertion SIO_000772 22372527 NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_provenance.
- NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_assertion wasDerivedFrom befree-2016 NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_provenance.
- NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_assertion wasGeneratedBy ECO_0000203 NP964059.RAyLtIrDUs_q6aoLH-53Rd7ZR1mpybjnWBE3DULRr15-Q130_provenance.